Tessa Therapeutics

The Temasek-backed company may embark on its next fundraise in Q4 or early next year.

SINGAPORE biotech Tessa Therapeutics on Monday (Aug 22) named a new CEO and president, Thomas Willemsen, a former Asia-Pacific senior vice president at Japan’s Takeda Pharmaceutical Company.

The company hopes to advance 2 key programmes targeted at cancer treatment.

IN a sign that it could be progressing towards certain milestones, Singapore-based immunotherapy biotech company Tessa Therapeutics continued to shore up its board of directors with another independen...

TEMASEK-BACKED biotech firm Tessa Therapeutics will open a 90,000 square foot commercial-scale cell therapy manufacturing facility in Singapore next year, it said in a press statement on Thursday.

SINGAPORE-BASED biotech company Tessa Therapeutics and China-Singapore Guangzhou Knowledge City (CSGKC) have formed a US$120 million joint venture (JV) in China to develop cell therapies for cancer.

TEMASEK Holdings, along with its investment unit Heliconia Capital and three other investors, has pumped US$80 million into Singapore-based biopharmaceutical company Tessa Therapeutics.

BIOPHARMACEUTICAL company Tessa Therapeutics announced it has successfully completed a US$80 million funding round led by Singapore investment company Temasek.

SINGAPORE-BASED Novena Global Lifecare Group (Novena) plans to list on the Taipei Exchange (TPEx) as part of its plan to expand regionally to meet buoyant demand from "affluent Asians to stay healthy ...